Virtual reality balance and exercise program for postmenopausal osteoporosis

The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients: A Randomized Controlled Trial

NA · Kirsehir Ahi Evran Universitesi · NCT07231822

This project tests whether virtual reality balance and exercise programs can help women aged 50–75 with postmenopausal osteoporosis improve balance and lower their risk of falls.

Quick facts

PhaseNA
Study typeInterventional
Enrollment50 (estimated)
Ages40 Years to 65 Years
SexAll
SponsorKirsehir Ahi Evran Universitesi (other)
Locations1 site (Center, Kirşehi̇r)
Trial IDNCT07231822 on ClinicalTrials.gov

What this trial studies

This interventional study enrolls postmenopausal women with osteoporosis confirmed by DEXA (T-score ≤ -2.5) who can walk independently and have adequate cognition. Participants receive either conventional treatment or a virtual reality–based exercise program (exergames) aimed at improving balance and gait. Outcomes will focus on changes in balance, walking speed, and fall risk measures to determine whether the VR intervention produces functional improvements. The trial is conducted at Kırşehir Ahi Evran University and excludes patients with secondary osteoporosis, recent lower-limb injury or surgery, significant comorbidities affecting balance, or intolerance to VR.

Who should consider this trial

Good fit: Ideal candidates are postmenopausal women aged 50–75 with osteoporosis (DEXA T-score ≤ -2.5), at least one year postmenopause, able to walk without aids, cognitively intact (e.g., MMSE ≥ 24), and willing to consent.

Not a fit: Patients with secondary osteoporosis, recent lower-limb fracture or surgery, severe cardiovascular, neurological, musculoskeletal, vestibular or visual disorders, intolerance to VR, or recent regular physiotherapy/exercise are unlikely to benefit or be eligible.

Why it matters

Potential benefit: If successful, the virtual reality program could improve balance and mobility and reduce the risk of falls and fractures in postmenopausal women with osteoporosis.

How similar studies have performed: Some studies using VR and exergames in older adults and people with balance problems have shown promising improvements in balance and gait, but evidence specifically for postmenopausal osteoporosis is limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Postmenopausal women aged 50-75 years
* Individuals diagnosed with osteoporosis based on Dual-Energy X-ray Absorptiometry (DEXA) measurement (T-score ≤ -2.5)
* Having been in menopause for at least 1 year
* Being able to walk independently (without the use of assistive devices)
* Volunteering to participate in the study and having provided informed consent
* Having adequate cognitive function (e.g., Mini Mental Test ≥ 24)

Exclusion Criteria:

* Secondary osteoporosis diagnosis (e.g. endocrine, metabolic or drug-induced causes)
* History of lower limb fracture or surgical intervention within the last 6 months
* Individuals with severe cardiovascular, neurological, or musculoskeletal disorders
* Individuals with vestibular or visual impairments that may affect balance
* Intolerance to virtual reality applications (e.g., dizziness, nausea, etc.)
* Individuals who have participated in a regular physiotherapy or exercise programme within the last 3 months

Where this trial is running

Center, Kirşehi̇r

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Osteoperosis, Postmenopausal osteoporosis, Virtual reality, balance

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.